Lupin Limited Annual Report 2024. Lupin’s consolidated revenues for the financial year 2023 stood at ₹16,641 crore compared to ₹16,405 crore in fy22, with a net profit of ₹430 crore in fy23. The combined revenue from india and the u.s.
This resulted in a 20% rise in the company’s overall revenue to. Q4 fy2023 were inr 14,786 mn, down 2.8% compared to inr 15,213 mn in q3 fy2023;
Global pharma major lupin limited has announced its debut in the s&p global sustainability yearbook 2024, underscoring its dedication to corporate sustainability.
Lupin receives approval from u.s.
Lupin’s consolidated revenues for the financial year 2023 stood at ₹16,641 crore compared to ₹16,405 crore in fy22, with a net profit of ₹430 crore in fy23.
Up 9.4% compared to inr 13,511 mn in q4 fy2022;
